Cargando…

Crosstalk of parkin and Ret in dopaminergic neurons

Detalles Bibliográficos
Autor principal:	Kramer, Edgar R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599211/ https://www.ncbi.nlm.nih.gov/pubmed/26202959

Ejemplares similares

The neuroprotective and regenerative potential of parkin and GDNF/Ret signaling in the midbrain dopaminergic system
por: Kramer, Edgar R.
Publicado: (2015)

Oxidative switch drives mitophagy defects in dopaminergic parkin mutant patient neurons
por: Schwartzentruber, Aurelie, et al.
Publicado: (2020)

Salidroside Protects Dopaminergic Neurons by Enhancing PINK1/Parkin-Mediated Mitophagy
por: Li, Ruru, et al.
Publicado: (2019)

Decreased NAD+ in dopaminergic neurons
por: Sison, Samantha L., et al.
Publicado: (2018)

Are PARKIN patients ideal candidates for dopaminergic cell replacement therapies?
por: Kunath, Tilo, et al.
Publicado: (2019)

Dopaminergic neurons: linking longevity with reproduction?
por: Tian, Xiaolin
Publicado: (2022)

Multi-story Parkin
por: Martinez, Aitor, et al.
Publicado: (2017)

Molecular Aspects of Dopaminergic Neurodegeneration: Gene-Environment Interaction in Parkin Dysfunction
por: Ali, Syed F., et al.
Publicado: (2011)

An Efficient and Versatile System for Visualization and Genetic Modification of Dopaminergic Neurons in Transgenic Mice
por: Tillack, Karsten, et al.
Publicado: (2015)

The inflammatory injury in the striatal microglia-dopaminergic-neuron crosstalk involved in Tourette syndrome development
por: Wang, Xueming, et al.
Publicado: (2023)

Parkin in cancer: Mitophagy-related/unrelated tasks
por: Eid, Nabil, et al.
Publicado: (2017)

Targeting RET–interleukin-6 crosstalk to impair metastatic dissemination in breast cancer
por: Morandi, Andrea, et al.
Publicado: (2014)

Mitochondrial Alterations by PARKIN in Dopaminergic Neurons Using PARK2 Patient-Specific and PARK2 Knockout Isogenic iPSC Lines
por: Shaltouki, Atossa, et al.
Publicado: (2015)

Crosstalk of Intercellular Signaling Pathways in the Generation of Midbrain Dopaminergic Neurons In Vivo and from Stem Cells
por: Brodski, Claude, et al.
Publicado: (2019)

Zebrafish GDNF and its co-receptor GFRα1 activate the human RET receptor and promote the survival of dopaminergic neurons in vitro
por: Saarenpää, Tuulia, et al.
Publicado: (2017)

Mitochondrial quality control beyond PINK1/Parkin
por: von Stockum, Sophia, et al.
Publicado: (2018)

Targeting RET-rearranged lung cancers with multikinase inhibitors
por: Sabari, Joshua K., et al.
Publicado: (2017)

Vulnerable Parkin Loss-of-Function Drosophila Dopaminergic Neurons Have Advanced Mitochondrial Aging, Mitochondrial Network Loss and Transiently Reduced Autophagosome Recruitment
por: Cackovic, Juliana, et al.
Publicado: (2018)

The Actin Cytoskeleton Is Involved in Glial Cell Line-Derived Neurotrophic Factor (GDNF)-Induced Ret Translocation into Lipid Rafts in Dopaminergic Neuronal Cells
por: Li, Li, et al.
Publicado: (2017)

Folic Acid Improves Parkin-Null Drosophila Phenotypes and Transiently Reduces Vulnerable Dopaminergic Neuron Mitochondrial Hydrogen Peroxide Levels and Glutathione Redox Equilibrium
por: Houlihan, Katherine L., et al.
Publicado: (2022)

Hydrocortisone-induced parkin prevents dopaminergic cell death via CREB pathway in Parkinson’s disease model
por: Ham, Sangwoo, et al.
Publicado: (2017)

ATG8-dependent LMX1B-autophagy crosstalk shapes human midbrain dopaminergic neuronal resilience
por: Jiménez-Moreno, Natalia, et al.
Publicado: (2023)

Quantitative proteomic analysis of Parkin substrates in Drosophila neurons
por: Martinez, Aitor, et al.
Publicado: (2017)

Pro-Survival Role for Parkinson's Associated Gene DJ-1 Revealed in Trophically Impaired Dopaminergic Neurons
por: Aron, Liviu, et al.
Publicado: (2010)

Nigral overexpression of alpha-synuclein in the absence of parkin enhances alpha-synuclein phosphorylation but does not modulate dopaminergic neurodegeneration
por: Van Rompuy, Anne-Sophie, et al.
Publicado: (2015)

Editorial: 2021 European Society for Medical Oncology (ESMO) Recommendations on Laboratory Diagnostics for RET Gene Fusions and Mutations: A New Era in Targeted Therapy for RET-Altered Solid Tumors
por: Parums, Dinah V.
Publicado: (2021)

Functional Crosstalk between CB and TRPV1 Receptors Protects Nigrostriatal Dopaminergic Neurons in the MPTP Model of Parkinson's Disease
por: Wi, Rayul, et al.
Publicado: (2020)

Rethinking treatment for RET-altered lung and thyroid cancers: selpercatinib approval by the EMA
por: Della Corte, C.M., et al.
Publicado: (2021)

RET Solvent Front Mutations Mediate Acquired Resistance to Selective RET Inhibition in RET-Driven Malignancies
por: Solomon, Benjamin J., et al.
Publicado: (2020)

Developmental impact of glutamate transporter overexpression on dopaminergic neuron activity and stereotypic behavior
por: Chohan, Muhammad O., et al.
Publicado: (2022)

Parkin deficiency exacerbate ethanol-induced dopaminergic neurodegeneration by P38 pathway dependent inhibition of autophagy and mitochondrial function
por: Hwang, Chul Ju, et al.
Publicado: (2016)

Is activation of GDNF/RET signaling the answer for successful treatment of Parkinson's disease? A discussion of data from the culture dish to the clinic
por: Conway, James A., et al.
Publicado: (2021)

Precision therapy for RET-altered cancers with RET inhibitors
por: Thein, Kyaw Z., et al.
Publicado: (2021)

RET kinase inhibitors for RET-altered thyroid cancers
por: Vodopivec, Danica M., et al.
Publicado: (2022)

RET signaling pathway and RET inhibitors in human cancer
por: Regua, Angelina T., et al.
Publicado: (2022)

Selective RET kinase inhibition for patients with RET-altered cancers
por: Subbiah, V, et al.
Publicado: (2018)

Crosstalk between insulin-like growth factor-1 and angiotensin-II in dopaminergic neurons and glial cells: role in neuroinflammation and aging
por: Rodriguez-Perez, Ana I., et al.
Publicado: (2016)

Absence of Ret Signaling in Mice Causes Progressive and Late Degeneration of the Nigrostriatal System
por: Kramer, Edgar R, et al.
Publicado: (2007)

Disinhibition Bursting of Dopaminergic Neurons
por: Lobb, Collin J., et al.
Publicado: (2011)

Parkinson's disease and dopaminergic neurons
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_f0opedgcsf44v4vvri1f5pitpu